Metron Medical Australia, Pty, Ltd.
AustraliaFDA applicant, unverified
- Devices
- 17
What Metron Medical Australia, Pty, Ltd. makes
Metron Medical Australia produces ultrasound-based therapeutic devices, including the Accusonic Advantage and Accusonic Plus series for deep tissue therapy, as well as VectorSonic and Sonic models for targeted ultrasound applications. Their VectorSurge line includes interferential therapy units (Models 470 and 500) and a Multi-Stim device for combined electrical and ultrasound stimulation. The Accusonic series (Models AS-260, AS-270, AP-170) and VectorSurge 4 are designed for physiotherapy and pain management treatments.
All listed devices fall under Class II regulatory classification in the US, with authorisation records maintained via FDA 510(k) submissions. The company is based in the United States and its products are registered under the FDA’s medical device registry system.
Catalogue
Search and filter all 17 devicesFrequently asked questions
How many devices does Metron Medical Australia, Pty, Ltd. have in the registry?
The registry currently lists 17 devices for Metron Medical Australia, Pty, Ltd.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Metron Medical Australia, Pty, Ltd.'s devices?
Among its 17 most recently registered devices, Metron Medical Australia, Pty, Ltd. has devices listed in FDA 510(k) (17 devices).
What risk classes do Metron Medical Australia, Pty, Ltd.'s devices fall under?
Among its 17 most recently registered devices, the classes recorded for Metron Medical Australia, Pty, Ltd.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Metron Medical Australia, Pty, Ltd. in the registry?
The most recently registered devices listed for Metron Medical Australia, Pty, Ltd. include ACCUSONIC ADVANTAGE, SONIC, MODEL SO-100, VECTORSURGE 5 MODEL 470 and MODIFICATION TO:ACCUSONIC PLUS, MODEL AP-100.